Update on gastrointestinal stromal tumor [GIST]

Ethiopian Medical Journal

Volumn 44, Issue 1, 2006, Pages 93-97

  Schneider, Jakob ^a  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

DRUG ANTAGONISM; GASTROINTESTINAL STROMAL TUMOR; HUMAN; PATHOLOGY; PROGNOSIS; REVIEW; RISK FACTOR;

GASTROINTESTINAL STROMAL TUMORS; HUMANS; PIPERAZINES; PROGNOSIS; PROTEIN-TYROSINE KINASES; PYRIMIDINES; RISK FACTORS;

EID: 33845690824     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (5)

1. Fletcher C D M, Berman J J, Corless C et al. Diagnosis of gastrointestinal stromal tumors: A conseasus approach. Int J Surg Pathol 2002; 10 (2): 81-9.
2. Mazur M T, Clark H B. Gastric stromal tumors: Reapprisal of histogenesis. Am J Surg Pathol 1983; 7: 507-19.
3. Kitamura Y, Hirota S, Nishida T. Gastrointestinal stromal tumors (GIST): A model for molecule-based diagnosis and treatment of solid tumors. Cancer Sci 2003; 94 (4): 315-20.
4. Brian P R, Singer S, Tsao C et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tuMors. Cancer Research 2001; 61: 8118-21.
5. Demetri G D, Titton R L, Ryan D P, Fletcher CDM. Case 32-2004: A 68-year-old man with a large retroperitoneal mass. N Engl J Med 2004; 351 (17): 1779-87